GSK unveils new cancer unit
September 17, 2008Research and Development Cancer, GSK
GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …
Amgen sells off two biotech products
September 16, 2008Research and Development biotech
Biotech pioneer Amgen has sold off two niche products to Biovitrum, along with the promotional rights to a third product, …
Latest news from Datamonitor
September 15, 2008Sales and Marketing NICE, rcc
UK watchdog's guidance knocks kidney cancer drugsThe UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted …
Lilly launches diabetes patient education programme
September 12, 2008Medical Communications, Sales and Marketing diabetes, patients
Lilly has launched an international diabetes education programme, the centrepiece of which is a tool for healthcare professionals to conduct …
Patient wins legal battle for Revlimid
September 12, 2008Sales and Marketing Cancer, Revlimid
A cancer patient has won access to cancer drug Revlimid in a court battle with his local PCT. West Sussex …
The potential and the perils of online recruitment
September 11, 2008Business Services careers, digi, recruitment
It's easy to be someone different on the internet – a recent conference on Second Life was attended by a …
Merck Serono takes lead role in antibody partnership
September 11, 2008Research and Development Merck Serono
Merck Serono has agreed to take on full responsibility for developing a promising antibody from its partner ZymoGenetics. The German …
Postcode lottery of care persists in England
September 11, 2008Sales and Marketing par
A new report identifies widespread variations in how much the NHS spends locally on different diseases. The King's Fund says …
Oxford BioMedica unsettled by chief executive’s departure
September 10, 2008Sales and Marketing Oxford BioMedica, biotech
Confidence has been shaken in Oxford BioMedica following news that its chief executive has stepped down just one month after …
Viehbacher leaves GSK for Sanofi
September 10, 2008Sales and Marketing GSK, Sanofi
Chris Viehbacher is set to leave GlaxoSmithKline for a lead role at Sanofi-Aventis after last year losing out to Andrew …
Government looks set to allow top-up fees
September 10, 2008Sales and Marketing Cancer, Karol Sikora, NICE
Patients in the UK could soon gain official clearance to pay ‘top up’ fees in order to receive the cancer …
Tapping into the audience’s imagination
September 9, 2008Medical Communications Best of Health, IPA, advertising, awards, event
Latest news from Datamonitor
September 9, 2008Sales and Marketing lifecycle
Drug lifecycle management could be the answer to the $100 billion questionGenerics are finding their way onto the drugs market …
European research centres unite to battle cancer
September 9, 2008Research and Development Cancer, EU, France, Netherlands, Sweden
Top oncology specialists across Holland, France and Sweden have formed a new alliance to improve cancer research and reduce treatment …
Danish court overturns Lipitor patent challenge
September 5, 2008Sales and Marketing Denmark, Lipitor, Pfizer, generics
A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …
Pfizer to co-market new Alzheimer’s drug
September 5, 2008Sales and Marketing Alzheimer's, Pfizer
Pfizer is to partner with American firm Medivation to develop and market a new drug for Alzheimer’s and Huntington’s disease.The …
Experts play down Inergy cancer risk
September 5, 2008Sales and Marketing Merck, cv
Heart specialists have told patients to continue taking Schering-Plough and Merck's cholesterol-lowering drug Inergy, despite a study indicating that it …
